Temozolomide Bests Nivolumab in Glioblastoma With Unmethylated MGMT Promoter
Overall and progression-free survival were superior with temozolomide.
Overall and progression-free survival were superior with temozolomide.
Researchers sought to develop and validate an MRI radiomics prediction model through a machine learning-based method to predict the survival of patients with glioma.
Researchers sought to evaluate the activity and safety of dabrafenib plus trametinib in adult patients with recurrent or progressive BRAF V600E -mutation–positive high-grade and low-grade glioma.
The researchers sought to assess the safety and efficacy of cabozantinib to treat brain metastases in patients with metastatic renal cell carcinoma.
From 2008 to 2017, the incidence of malignant brain tumors decreased for all ages combined, but increased among children and adolescents.
The combination of nivolumab with ipilimumab is an effective treatment option for patients with advanced melanoma with asymptomatic brain metastases
Occult brain metastasis is identified in about 4 percent of patients with metastatic renal cell carcinoma (mRCC).
Researchers hope their findings could lead to targeted interventions to improve cognitive outcomes in pediatric brain tumor survivors from families with low socioeconomic status.
A novel workflow that combines advanced optical imaging with an artificial intelligence algorithm may accurately diagnose brain tumors in real time in the operating room.
Unlike previous studies, the researchers found that in their practice, no-treatment rates between elderly and nonelderly patients with biopsy-proven NMSCs were significantly different.